Takeda Pharmaceutical (TAK) Enterprise Value (2018 - 2025)
Takeda Pharmaceutical (TAK) has 8 years of Enterprise Value data on record, last reported at -$2.7 billion in Q1 2025.
- For Q1 2025, Enterprise Value fell 2511.02% year-over-year to -$2.7 billion; the TTM value through Mar 2025 reached -$2.7 billion, changed N/A, while the annual FY2025 figure was -$2.7 billion, 2444.83% down from the prior year.
- Enterprise Value reached -$2.7 billion in Q1 2025 per TAK's latest filing, down from -$101.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$101.8 million in Q1 2024 and bottomed at -$9.5 billion in Q1 2021.
- Average Enterprise Value over 5 years is -$4.7 billion, with a median of -$4.0 billion recorded in 2023.
- Peak YoY movement for Enterprise Value: surged 97.48% in 2024, then plummeted 2511.02% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$9.5 billion in 2021, then grew by 22.83% to -$7.3 billion in 2022, then soared by 44.83% to -$4.0 billion in 2023, then soared by 97.48% to -$101.8 million in 2024, then tumbled by 2511.02% to -$2.7 billion in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$2.7 billion in Q1 2025, -$101.8 million in Q1 2024, and -$4.0 billion in Q1 2023.